Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Real-time Quote. Real-time Tradegate - 10/17 11:50:33 am
118.176 EUR   -1.19%
10:18a BAYER : foundations bring tech pioneers physicians and social entrep..
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 BASF CEO says to look at more seed M&A after Bayer deal
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
11:09aDJHUTCHISON CHINA MEDITECH : AstraZeneca Say Drug Shows Potential to Treat Lung Ca..
08:48aDJDaimler Charts Leaner Approach -- WSJ
08:46aDJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
10/13 GLAXOSMITHKLINE : shingles vaccine gets approval in Canada
10/13 ASPEN PHARMACARE : UK anti-trust regulator investigates South Africa's Aspen Pha..
10/13DJROCHE : Gets CHMP Recommendation for Lung Cancer Treatment Alecensa
10/12DJSHIRE PLC SHIRE PLC : Notice Of Results
10/11DJMERCK AND : Ebola Vaccines Show Promise in New Study
10/11DJPFIZER : Tightens Focus on Prescription Drugs -- WSJ
10/11DJCompanies Chase Spinoff Bump -- WSJ
10/11DJTHE REASON INVESTORS LOVE SPINOFFS : Juicier Returns
10/10DJPFIZER : Considers a Sale or Spinoff of Its Consumer Healthcare Business -Update
10/10DJPFIZER : Reviews Consumer Healthcare Business Options; Could Include Spinoff or ..
10/06DJBAYER : Halts Phase 3 Study on New Xarelto Indication
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
10/05DJAppeals Court Rules Against Amgen in Patent Case
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ASTRAZENECA : Drug industry gives up legal battle over new UK cost curbs
10/05DJJOHNSON & JOHNSON : Abandoning Insulin Pumps
10/05DJSHIRE PLC SHIRE PLC : Director/Pdmr Shareholding
10/05 BTG : to buy Roxwood Medical for up to $80 million
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03DJSHIRE PLC SHIRE PLC : Director/Pdmr Shareholding -3-
10/03DJSHIRE PLC SHIRE PLC : Director/Pdmr Shareholding -2-
10/03DJSHIRE PLC SHIRE PLC : Director/Pdmr Shareholding
10/03DJMERCK : to Invest EUR35 Million in Italy Plant's Production Line
10/03DJSHIRE : Files Antitrust Lawsuit Against Rival -- WSJ
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts -- Update
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts
10/02DJSHIRE PLC SHIRE PLC : Total Voting Rights
10/02DJSANOFI : Appoints Stefan Oelrich to Executive Committee
10/02 ASTRAZENECA : Tell us how Brexit will work, British companies demand
09/30DJELI LILLY AND : Reshuffles Top Ranks -- WSJ
09/29DJMERCK AND : Abandons New Hepatitis C Drugs Amid Crowded Market
09/29DJELI LILLY AND : Names Joshua Smiley CFO
09/29 Merck to stop development of hepatitis C treatments
09/29DJJOHN ARNOLD : AbbVie, Amgen Settle Humira Patent Fight -- WSJ
09/28DJABBVIE : Amgen Reach Settlement in Humira Patent Dispute -- Update
09/28DJJOHN ARNOLD : AbbVie, Amgen Reach Settlement in Humira Patent Dispute
09/28 LPC-Europe's leveraged loan market shows strength and depth
09/28 MERCK KGAA CFO : 2017 profit guidance "damn challenging"
09/28DJROCHE : Gets Switzerland Approval for Multiple Sclerosis Treatment
09/28 NOVARTIS : forges UC Berkeley pact, sees drug hopefuls in three years
Financials (€)
Sales 2017 48 368 M
EBIT 2017 9 231 M
Net income 2017 5 396 M
Debt 2017 12 235 M
Yield 2017 2,32%
P/E ratio 2017 19,67
P/E ratio 2018 17,76
EV / Sales 2017 2,30x
EV / Sales 2018 2,19x
Capitalization 98 903 M
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
BAYER19.19%116 409
JOHNSON & JOHNSON18.42%365 346
NOVARTIS13.23%226 956
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751
AMGEN25.17%132 728
SANOFI8.71%125 652
CELGENE CORPORATION17.89%106 955
BRISTOL-MYERS SQUIBB COMPANY11.72%104 381
GLAXOSMITHKLINE-2.94%99 014
NOVO NORDISK A/S16.92%97 056
ABBOTT LABORATORIES42.28%94 917
ELI LILLY AND COMPANY17.68%94 630
ASTRAZENECA15.54%86 688
ALLERGAN PLC-2.14%66 330
SHIRE-17.85%47 315
TAKEDA PHARMACEUTICAL CO LTD28.48%43 783
ASTELLAS PHARMA INC-9.75%27 057
JIANGSU HENGRUI MEDICINE CO LTD38.26%26 885
CHUGAI PHARMACEUTICAL CO LTD54.69%25 887